No compensation for the Commonwealth: Australia v Sanofi

by

In the keenly awaited decision in Commonwealth of Australia v Sanofi1, the Federal Court has dismissed the Commonwealth’s $325 million claim for compensation made against Sanofi arising from a patent infringement suit brought against Apotex Australia (Apotex), the Australian subsidiary of the Canadian generic drug company Apotex Canada.

Read more here >>

BSc(Hons) LLB LLM FIPTA MRACI

Malcolm is a Principal of Phillips Ormonde Fitzpatrick and Phillips Ormonde Fitzpatrick Lawyers. His practice is split between litigious matters and his work as a patent attorney.